Wednesday, November 26, 2014 Last update: 8:03 PM
FreshNews.com - Covering Large & Obscure Tech Companies Since 1996

Conversant Bio Releases Comprehensive SLE Guide for Researchers

Companies mentioned in this article: Conversant Bio

HUNTSVILLE, AL -- (Marketwired) -- 09/03/14 -- Conversant Bio, a global leader in supplying the highest-quality human tissue and viable cell samples, today announced it is publishing a guide to the basics of systemic lupus erythematosus, or SLE. The e-book The Researcher's Ultimate Guide to Systemic Lupus Erythematosus, is available as a free download at http://www.conversantbio.com/the-researchers-ultimate-guide-to-systemic-lupus-erythematosus.

Systemic lupus erythematosus is a chronic autoimmune disorder that causes protracted inflammation of almost any organ system -- most often, the skin, joints, kidneys, blood cells, and nervous system. Of the four types of lupus, SLE is the most common, currently afflicting approximately 1.5 million Americans. Though there is no cure, researchers are working toward solving the disease. This guide offers valuable, real-world information to those researchers, including:

  • Basics of SLE, including symptoms and causes
  • Explanations of how patients are diagnosed and how the disease affects their lifestyles
  • Medications and treatments
  • Research challenges
  • Case studies

The e-book also details how quality blood samples from SLE patients are critical for researchers seeking a cure.

"It's important for researchers to know that autoimmune specimens open up the possibility to advance their SLE research through sample specificity and flexibility," says Luke Doiron, chief commercial officer for Conversant Bio. "Our goal with this e-book is to share crucial information about SLE so we can help researchers optimize their goals."

To download The Researcher's Ultimate Guide to Systemic Lupus Erythematosus, visit http://www.conversantbio.com/the-researchers-ultimate-guide-to-systemic-lupus-erythematosus.

About Conversant Bio

Conversant Bio provides researchers around the world with hyper-annotated tissue samples in order to conduct informed, cutting-edge investigations into many of today's most problematic diseases. With a large prospective collections network of 36 U.S.-based clinical sites and an IRB-reviewed chain of custody quality control system, Conversant Bio provides the highest-quality samples on time and on budget. For additional information about Conversant Bio's services, visit the company's website at http://www.conversantbio.com.


Contact:

Contact information
Luke Doiron
Chief Commercial Officer
(866) 838-2798
luke.doiron@conversantbio.com